Two Dickinson Street Co-op

Global Home Medical Equipment (HME) Market and Technology Report 2022: Market Revenue for 2020 and 2021, Estimates for 2022, and CAGR Projections Through 2027

Retrieved on: 
Friday, September 23, 2022

DUBLIN, Sept. 23, 2022 /PRNewswire/ --The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 23, 2022 /PRNewswire/ --The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment.
  • Among the various diseases managed or treated with HME, diabetes accounted for the largest share of the global HME market in 2021.
  • The increasing prevalence of respiratory diseases, diabetes, sleep disorders, hypertension and a rapidly expanding senior population are pushing the growth of the global home medical equipment market.

Home Medical Equipment (HME) Technologies and Global Markets Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 19, 2022

The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment.
  • The increasing prevalence of respiratory diseases, diabetes, sleep disorders, hypertension and a rapidly expanding senior population are pushing the growth of the global home medical equipment market.
  • Also, pandemics like the 2019 novel coronavirus (COVID-19) drive the global demand for home medical equipment.

Global Injectable Drug Delivery Market Report 2022-2028 with Key Company Analysis of Pfizer, GSK, Eli Lilly, Baxter and BD and Co - ResearchAndMarkets.com

Retrieved on: 
Friday, July 15, 2022

The "Global Injectable Drug Delivery Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Injectable Drug Delivery Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the global injectable drug delivery market during the forecast period can be attributed to the increasing prevalence of chronic diseases such as diabetes, among others across the globe.
  • The global injectable drug delivery market is segmented based on the mode of administration, usability, and end-user.
  • The major companies serving the global injectable drug delivery market include Becton, Dickinson and Co., Baxter International Inc., Eli Lilly and Co., GlaxoSmithKline PLC, and Pfizer Inc., among others.

S3 Ventures Announces $250M Fund VII – The Largest Venture Capital Fund Focused on Texas-based Startups

Retrieved on: 
Wednesday, March 9, 2022

S3 Ventures today announced a $250 million Fund VII the latest and largest venture capital fund focused on the state of Texas.

Key Points: 
  • S3 Ventures today announced a $250 million Fund VII the latest and largest venture capital fund focused on the state of Texas.
  • With $900 million in assets under management, the Austin-based VC is the largest firm that primarily invests in Texas-based startups.
  • Since its founding in 2005, S3 Ventures has been backed by one limited partner a highly philanthropic family with a multibillion-dollar foundation focused on addressing social inequities.
  • Founded in 2005, S3 Ventures is an Austin-based venture capital firm that has raised seven funds with more than $900 million in assets under management.

Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding to Advance Manufacturing and Expand Commercialization of NX One Platform

Retrieved on: 
Thursday, December 16, 2021

The financing was led by RA Capital Management with participation by Section 32 as well as previous investors.

Key Points: 
  • The financing was led by RA Capital Management with participation by Section 32 as well as previous investors.
  • We are excited to deliver a broadly available solution for customers spanning startups and academic labs to the largest life science firms.
  • The funding announced today will allow us to expand our team substantially to support our mission to democratize biological tools.
  • Nodexus is a life science tools company that develops platforms to accelerate biological workflows and make them more widely accessible.

Global Autoinjectors Markets Report 2021-2026: Growing Prevalence of Targeted Therapies, Rising Incidence of Anaphylaxis, and Increasing Number of Regulatory Approvals - ResearchAndMarkets.com

Retrieved on: 
Monday, November 29, 2021

The Asia-Pacific market for autoinjectors should grow from $10.2 billion in 2021 to $22.6 billion by 2026, at a CAGR of 17.2% for the period of 2021-2026.

Key Points: 
  • The Asia-Pacific market for autoinjectors should grow from $10.2 billion in 2021 to $22.6 billion by 2026, at a CAGR of 17.2% for the period of 2021-2026.
  • The growing prevalence of targeted therapies, rising incidence of anaphylaxis, and the increasing number of regulatory approvals are factors responsible for this market growth.
  • Autoinjectors are pen-like devices used to deliver a fixed dose of a drug to a patient and are intended for self-administration.
  • Autoinjectors are gradually becoming the gold standard in the treatment of indications such as anaphylaxis, multiple sclerosis and rheumatoid arthritis.

Global Tissue Diagnostics Market Outlook: A 6.4 Billion Market by 2026 with CAGR of 6% Forecast During 2021 to 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 17, 2021

The global tissue diagnostics market should reach $6.4 billion by 2026 from $4.7 billion in 2021 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2021 to 2026.

Key Points: 
  • The global tissue diagnostics market should reach $6.4 billion by 2026 from $4.7 billion in 2021 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2021 to 2026.
  • The general culture test segment of the global tissue diagnostics market is expected to grow from $3.0 billion in 2021 to $3.9 billion in 2026 at a CAGR of 5.4% for the forecast period of 2021 to 2026.
  • The AST/ID test segment of the global tissue diagnostics market is expected to grow from $1.1 billion in 2021 to $1.5 billion in 2026 at a CAGR of 7.1% for the forecast period of 2021 to 2026.
  • Structure and current market size of the market for tissue diagnostics as outlined with forecasts through 2026.

Global High Content Screening/Imaging Market (2021 to 2026) - Featuring Thermo Fisher Scientific, Yokogawa Electric and Logos Biosystems Among Others

Retrieved on: 
Friday, September 3, 2021

The current report offers a detailed picture of the high content screening/imaging market.

Key Points: 
  • The current report offers a detailed picture of the high content screening/imaging market.
  • This report highlights the current and future market potential for high content screening/imaging and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market.
  • The report also covers market projections through 2026, as well as key market players.
  • It covers the overall high content screening/imaging market including instrument or platform, consumables (reagents and kits), software and analytics, and services.

Global DNA Sequencing Research Report 2021: Focus on Research, Applied and Clinical Markets - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 2, 2021

The "Global DNA Sequencing: Research, Applied and Clinical Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global DNA Sequencing: Research, Applied and Clinical Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report reviews the leading sequencing technologies and describes why genetic variation is essential in clinical testing.
  • The DNA sequencing industry has achieved notable growth from its beginnings to become a vital sector in the life sciences industry.
  • Significant developments in the research space include the growth of large-scale sequencing initiatives and support for sequencing by major governmental funding agencies.

Valued to be $15.1 Billion by 2026, Healthcare Education Solutions Slated for Robust Growth Worldwide

Retrieved on: 
Thursday, August 26, 2021

We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.

Key Points: 
  • We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.
  • Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more.
  • The U.S. Market is Estimated at $3 Billion in 2021, While China is Forecast to Reach $3.1 Billion by 2026
    The Healthcare Education Solutions market in the U.S. is estimated at US$3 Billion in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.